LatestHeadlines

Sign In

Sign In

Sign In

Zepbound

Obesity drugs could reduce US mortality by up to 6.4%

Obesity drugs could reduce US mortality by up to 6.4%

Obesity drug maker Novo Nordisk ousts CEO as competition weighs

Obesity drug maker Novo Nordisk ousts CEO as competition weighs

Zepbound resolves sleep apnea in up to 52% of patients, says Lilly

Zepbound resolves sleep apnea in up to 52% of patients, says Lilly

Lilly’s Zepbound surpasses Wegovy in new US prescriptions for 1st time

Lilly’s Zepbound surpasses Wegovy in new US prescriptions for 1st time

Lilly’s weight-loss drug Zepbound gets US, UK approval to rival Wegovy

Lilly’s weight-loss drug Zepbound gets US, UK approval to rival Wegovy